Background-Atherosclerotic plaque that shows echo signal attenuation (EA) without associated bright echoes is sometimes observed by intravascular ultrasound but its clinical significance remains unclear. We investigated the impact of EA on coronary perfusion and evaluated the pathological features of plaque with EA. Methods and Results-We studied 687 native coronary lesions in 687 consecutive patients (336 with acute coronary syndrome and 351 with stable angina pectoris) who underwent intravascular ultrasound before percutaneous coronary intervention. By subgroup analysis, 60 lesions (30 lesions with EA) treated with directional coronary atherectomy underwent pathological examination. The Thrombolysis in Myocardial Infarction (TIMI) flow grade and myocardial blush grade after percutaneous coronary intervention were compared between lesions with and without EA in 627 lesions except directional coronary atherectomy subgroup. EA was observed in 245 lesions (35.7%), and coronary flow after percutaneous coronary intervention was worse for lesions with EA than without (final TIMI grade of 0 to 2: 15.4% versus 2.4%, PϽ0.001; final myocardial blush grade of 0 to 2: 45.6% versus 21.4%, PϽ0.001). Multivariate analysis revealed a significant association between no reflow (TIMI grade 0 to 2) and EA (odds ratio, 5.59; 95% CI, 2.64 to 11.85; PϽ0.001), a baseline TIMI grade of 0 to 2 (odds ratio, 5.91; 95% CI, 2.79 to 12.5; PϽ0.001), and a large reference area (odds ratio, 3.08; 95% CI, 1.40 to 6.76; Pϭ0.005) after controlling for other associated factors. Pathological examination revealed a significantly higher frequency of lipid-rich plaque with microcalcification in lesions with EA. Conclusions-Atherosclerotic plaque with EA showed a significant association with no reflow after percutaneous coronary intervention, suggesting the existence of fragile components susceptible to distal embolization. (Circ Cardiovasc Intervent. 2009;2:444-454.)
P ercutaneous coronary intervention (PCI) is widely performed in patients with coronary artery disease to restore adequate coronary blood flow, but the no-reflow phenomenon is common after PCI 1, 2 and is associated with a poor clinical outcome. 3, 4 Several studies have suggested that preintervention intravascular ultrasound (IVUS) findings, such as the plaque volume, 5, 6 intracoronary thrombus, 7 lipid pool, 8, 9 and positive remodeling, 9 may be related to the no-reflow phenomenon after PCI. In addition, a recent IVUS study revealed that plaque with ultrasonic attenuation might be related to deterioration of coronary flow after PCI for acute coronary syndrome (ACS). 10, 11 We hypothesized that atherosclerotic plaque with echo signal attenuation (EA) was susceptible to distal embolization that might result in inadequate restoration of flow after PCI in patients with stable angina pectoris (SAP) or ACS. Accordingly, we evaluated the impact of EA on coronary flow and myocardial perfusion during PCI. We also investigated plaque specimens obtained by directional coronary atherectomy (DCA) to assess the pathological features of lesions with and without EA.
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Methods
Study Population
Of 1080 patients undergoing PCI at Tsuchiura Kyodo Hospital from June 2004 to May 2007, 687 patients (535 men and 152 women) who received preintervention IVUS with satisfactory image quality were investigated to assess 687 native coronary artery lesions, including 336 culprit lesions for ACS (acute myocardial infarction in 176, ST-segment elevation myocardial infarction in 131, non-ST-segment elevation myocardial infarction in 45, and unstable angina pectoris [UAP] in 160) and 351 culprit lesions for SAP. ST-segment elevation myocardial infarction was diagnosed from ST-segment elevation Ͼ1.0 mm in at least 2 contiguous electrocardiographic leads and elevation of creatine kinase (CK; Ͼ3 times above the upper limit of normal), whereas an increase of CK without ST-segment elevation was defined as non-ST-segment elevation myocardial infarction. UAP was defined as angina with a progressive crescendo pattern or angina at rest without an increase of CK. In-stent restenotic lesions, bypass grafts lesions, multiple culprit lesions, heavily calcified lesions, lesions treated with Rotablator, and lesions treated with a distal protection device were excluded. The presence of EA on IVUS was defined as atherosclerotic plaque showing ultrasound signal attenuation without very high intensity echo reflectors that involved Ͼ90 degrees of the vessel circumference and had a length of Ͼ1 mm (Figure 1 ). Lesions were divided into a group with EA (group A) and a group without EA (group NA) for comparison. By subgroup analysis, 60 lesions (30 with EA and 30 without) treated with DCA underwent pathological examination, and these lesions were excluded from the analysis of coronary flow after PCI and clinical follow-up to avoid device-related potential confounders. This study was approved by the Institutional Review Committee of Tsuchiura Kyodo Hospital, and all patients gave informed consent.
Study Protocol
Before PCI, all patients received intravenous heparin (8000 to 10 000 IU) and intracoronary nitroglycerin (0.2 mg). In patients with ACS, an aspiration catheter (TRANVAS Thrombuster II, KANEKA Medics Co, Osaka, Japan or Eliminate, Clinical Supply Co, Gifu, Japan) was used before IVUS. The IVUS catheter (Atlantis SR Pro, 2.5F, 40 MHz, Boston Scientific, Natick, Mass) was pulled back automatically at 0.5 mm/s from the distal to proximal side of the culprit lesion. After IVUS, conventional PCI was performed, with the strategy being selected by the interventionist. The angiographic end point was Ͻ25% residual stenosis on quantitative coronary angiography. After achieving this end point, IVUS was repeated to confirm optimal stent deployment, and an additional PCI was performed for a suboptimal result. 
Analysis of IVUS Findings
Two experienced observers who were blinded to the angiographic findings analyzed the IVUS images. Quantitative measurements and qualitative assessment were performed according to the American College of Cardiology Clinical Expert Consensus Document on IVUS. 12 The culprit lesion was defined as the site of the smallest lumen, and the reference site was set at the most normal-looking region within 10 mm proximal to it. The cross-sectional areas of the external elastic membrane (EEM-CSA) and the lumen were measured at the lesion and reference site. The cross-sectional area of the plaque was calculated by subtracting cross-sectional area of the lumen from EEM-CSA, and the plaque burden was calculated as plaque CSA divided by EEM-CSA ϫ100 (%). Positive remodeling was defined as existing when the culprit lesion showed a Ͼ5% increase of EEM-CSA relative to the reference site. A culprit lesion was defined as being eccentric if the eccentricity index (the thinnest plaque dimension divided by the width of the opposite wall) was Ͻ0.5. 13 Lipid core was defined as a core of low-echoic material or echolucent material covered by a high-echoic layer of plaque. Bright echoes with Ͻ90 degrees of acoustic shadowing were defined as mild calcification. The EEM-CSA of lesions with EA was measured by using the nearest traceable section for reference.
Angiographic Analysis
Coronary angiograms were reviewed by 2 experienced observers who were unaware of the IVUS findings. Quantitative coronary angiography was performed with a CMS-MEDIS system (Medis Medical Imaging Systems, Leiden, The Netherlands). The length, minimal lumen diameter, and reference lumen diameter of the culprit lesion were measured. Coronary flow was assessed according to the Thrombolysis in Myocardial Infarction (TIMI) flow grade 14 and corrected TIMI frame count (CTFC). 15 Angiographic no reflow was defined as TIMI grades 0 to 2, whereas normal flow was TIMI grade 3 without any evidence of dissection, significant stenosis, or vasospasm. In the analysis of CTFC, occlusion or markedly slow flow was defined as a CTFC Ͼ40, and the frequency of lesions with inadequate flow (CTFC Ͼ40) was determined. Myocardial perfusion was assessed by the myocardial blush grade (MBG). 16 The left ventricular ejection fraction was calculated from contrast left ventriculograms. In patients with an elevated end-diastolic left ventricular pressure or congestive heart failure (CHF), left ventriculography was not performed at the time of primary PCI and performed later before discharge.
In-Hospital Clinical Outcome
The clinical data were shown in Table 1 . Periprocedural myocardial damage was assessed in 128 UAP and 323 SAP lesions from 627 lesions except DCA subgroup. Elevation of CK above the 99th percentile of the reference range after PCI was defined as indicating periprocedural myocardial necrosis, whereas an increase of CK by Ͼ3 times above the upper reference limit after PCI was defined as indicating MI. In-hospital complications and outcome factors assessed were potentially fatal arrhythmias (ventricular tachycardia, ventricular fibrillation, and advanced atrioventricular block), CHF Data are presented as meanϮSD or n (%). A indicates attenuation; NA, nonattenuation; LAD, left anterior descending artery; RCA, right coronary artery; LCX, left circumflex artery; LMT, left main trunk; RD, reference diameter; MLD, minimal lumen diameter; LV, left ventricular; EEM, external elastic membrane; CSA, cross-sectional area.
*Lesion complexity was assessed according to the modified classification of the ACC/AHA. †EEM CSA Ϫ lumen CSA. ‡Plaque area divided by (EEM-CSA) ϫ100, presented as medians with interquartile ranges. §Lesion EEM CSA/proximal reference EEM CSA Ͼ1.05.
Bright echoes with an arc Ͻ90 degrees on IVUS.
(the presence of a third heart sound, Killip class Ն2, Forrester subset Ն2, or evidence of radiographic pulmonary congestion), disabling stroke, reinfarction, target vessel revascularization, cardiac surgery, and cardiac death.
Follow-Up
Follow-up for 1 year after discharge was completed in 591 patients (94.3%) (278 with ACS and 313 with SAP), and clinical information was collected and assessed in these patients. 2 . TIMI flow grade during PCI. A TIMI grade of 0 to 2 was significantly more common in group A than group NA among both patients with ACS and SAP after the first balloon inflation (ACS, 46.5% versus 9.1%; SAP, 15.1% versus 1.7%) and also at final angiography (ACS, 21.7% versus 4.0%; SAP, 5.8% versus 1.3%). 
Histopathologic Examination
Tissues obtained during DCA were immediately fixed by immersion in 10% buffered formalin and then were embedded in paraffin. Serial sections (5-m thick) were cut and stained with hematoxylin-eosin to detect cholesterol clefts, hemosiderin, and thrombus and with Von-Kossa stain to identify calcification. To identify macrophages, immunostaining with an anti-CD-68 antibody (M814 DAKO) was performed. The total and segment area of each plaque component were quantified by planimetry at a low magnification (ϫ40) in randomly selected 3 sections from each lesion, and the mean values were used for further analysis. In each section, the percent area of the following 4 tissues was calculated and was averaged for each lesion: (1) fibrous tissue (few cells and dense collagen fibers), (2) lipid-rich atheromatous tissue (foam cells, cholesterol clefts, and acellular debris), (3) hypercellular tissue (a loose connective tissue matrix containing numerous stellate cells), and (4) thrombus (fibrin deposits). 17 In addition, the presence of macrophages, cholesterol clefts, hemosiderin, microcalcification (small calcium flecks Ͻ50 m in diameter), and dense calcification (larger calcified masses) was semiquantitatively graded in each section (0, absent; 1, sparse; 2, abundant), and the mean grade for each lesion was calculated. Histopathologic assessment was done by 2 pathologists who were unaware of the clinical data. Figure 4 . MBG during PCI. An MBG of 0 to 2 was significantly more common in group A than group NA after the first balloon inflation (ACS, 65.1% versus 44.0%; SAP, 26.8% versus 11.4%) and at final angiography (ACS, 54.3% versus 35.4%; SAP, 32.6% versus 11.0%). 
Statistical Analysis
Results
Baseline Clinical Characteristics
There was a high level of agreement regarding the identification of EA (intraobserver agreement, 97.4%; ϭ0.94; interobserver agreement, 91.4%; ϭ0.81; Table 1 ). EA was observed in 245 of 687 lesions (35.7%), being more frequent in patients with ACS than those with SAP (43.8% versus 27.9%, PϽ0.001). There were no significant differences of baseline clinical characteristics between group A and group NA among patients with ACS or SAP.
Baseline Lesion Characteristics
The angiographic reference diameter, reference EEM-CSA, lesion EEM-CSA, lesion plaque area, and plaque burden on IVUS were significantly greater in group A than group NA for both patients with ACS and those with SAP ( Table 2 ). Coronary flow before PCI was similar between groups A and NA among both patients with ACS and those with SAP. The frequency of positive remodeling, eccentricity, and mild calcification were significantly higher in group A among both patients with ACS and those with SAP. More thrombus and lipid cores were observed in group A than group NA in patients with SAP.
Procedural Results, Hospital Course, and 1-Year Outcome
The post-PCI minimal lumen diameter was significantly larger in group A than in group NA among both patients with ACS and those with SAP. TIMI grade, CTFC, and MBG after initial balloon inflation were worse in group A than group NA irrespective of the clinical presentation (PϽ0.05), and the difference between the 2 groups remained significant at final angiography (Figures 2 through 4) . Deterioration of TIMI flow grade and MBG during PCI was more frequent in group A (deterioration of TIMI grade: 16.3% versus 5.7% in ACS patients, 7.0% versus 0.4% in patients with SAP; deterioration of MBG: 24.0% versus 10.3%, 9.3% versus 0.4%, respectively, PϽ0.01). The peak CK level and the frequency of periprocedural myocardial necrosis and MI were significantly higher among both patients with UAP and those with SAP from group A than group NA (Table 3 ). Both in hospital and up to 1 year after discharge, CHF was significantly more common in patients with ACS from group A than group NA (in-hospital: 27.1% versus 12.6%, Pϭ0.001, Table 4 ; 1 year: 7.6% versus 1.9%, Pϭ0.03, Table 5 ). During 1-year follow-up, total cardiac events, including MACE (cardiac death, ischemic target vessel revascularization, and reinfarction), cardiac surgery, fatal arrhythmias, CHF, and UAP, were more frequent in ACS patients from group A (Pϭ0.005; Table 5 ).
No-Reflow After PCI
There was no reflow after PCI (TIMI grade 0 to 2) in 43 lesions (6.9% Pϭ0.005) showed significant and independent associations with no reflow, whereas many associated factors were found by univariate analysis ( Table 6 ). The variables entered into multivariate logistic regression analysis were a baseline TIMI grade 0 to 2, presence of EA, ACS, primary aspiration, current smoker, EF Ͻ40%, left anterior descending lesion, long lesion, previous MI, treatment with statins, ticlopidine, or aspirin, and IVUS findings. The Hosmer and Lemeshow test provided P values of 0.896 in ACS, 0.451 in SAP, and 0.891 in all patients, respectively, which indicated a proper goodness of fit for these models.
Histological Assessment of DCA Samples
Clinical and angiographic characteristics of the patients who underwent DCA were similar between the groups with and without EA, and these variables were comparable with those in 627 lesions except DCA subgroup ( Table 7) . Histopathologic examination revealed a significantly higher prevalence of lipid-rich atheromatous tissue and a lower percent area of fibrous tissue in lesions with EA than in those without ( Table  8 ). Macrophage infiltration, cholesterol clefts, and microcalcification were all significantly more abundant in the lesions with EA (PϽ0.05; Figures 5 and 6 ).
Discussion
In this study, coronary flow and myocardial perfusion after PCI were worse in patients with either ACS or SAP whose culprit lesion showed EA on IVUS. Multivariate analysis revealed a significant association between no reflow after PCI and EA along with a baseline TIMI grade of 0 to 2 and a large reference area. EA was significantly more frequent in the culprit lesions of ACS than in those of SAP, although it was common in SAP. Our findings are supported by a recent report 11 that the plaque with EA was observed in 25.6% of patients with ACS and was associated with severe and complex lesion morphology, reduced blood flow before PCI, and especially no reflow after PCI. Interestingly, and contrary to the results of this study, EA was not found among patients with SAP in the other study. However, we found that 27.9% of 351 culprit lesions in patients with SAP had EA on preintervention IVUS, and these lesions were associated with worse coronary flow and worse myocardial perfusion after PCI. These findings were in agreement with previous studies. 18, 19 EA was predominantly found in lesions from vessels with a large reference diameter and a significant plaque burden, and these lesions showed a high frequency of positive remodeling, eccentricity, and mild calcification. According to a recent study, no reflow after PCI for ACS is solely attributable not only to thrombus but also to plaque components from atheromatous lesions. 20 Other studies using IVUS have also shown that a large culprit vessel size and a lipid pool-like plaque component are related to no reflow after PCI, 8, 9 indicating that both plaque volume and plaque components are important. The present findings were consistent because significant univariate predictors of no reflow after PCI included a large angiographic reference diameter, large plaque burden on IVUS, large lesion EEM area, and positive remodeling, whereas lesions with EA and a large reference area on IVUS were identified by a multivariate analysis. Furthermore, histopathologic examination of specimens ob- tained by DCA revealed a significantly higher prevalence of lipid-rich plaque, macrophage infiltration, cholesterol clefts, thrombus, and microcalcification in lesions with EA than in those without, suggesting that the presence of EA indicates fragile plaque susceptible to distal embolization with consequent no reflow after PCI. The present histopathologic findings were also consistent with previous reports. 18 A large plaque burden and heterogeneous plaque components, includ- ing cholesterol clefts and/or microcalcification, might scatter the ultrasound beam and thus cause EA. Microcalcification of coronary plaques may primarily occur at sites of apoptosis or lipid cores, 21 and Ehara et al 22 reported that spotty calcification with an arc Ͻ90 degrees on IVUS might be related to fibrofatty plaque and positive remodeling linked with plaque vulnerability. The high frequency of microcalcification that we detected in lesions with EA might also suggest plaque instability. In contrast to a previous report, 10 we found that the final coronary flow (TIMI flow grade and CTFC) and final myocardial perfusion (MBG) after PCI were worse in both patients with ACS and those with SAP if their lesions showed EA, suggesting that further myocardial damage may occur during PCI in patients with EA. This is supported by our findings that periprocedural myocardial necrosis and MI were more frequent in both patients with UAP and EA and those with SAP and EA, whereas there was a significantly higher incidence of CHF and total cardiac events in patients with ACS and EA. Limbruno and De Caterina 23 reported that selective distal protection for high-risk lesions might prevent or reduce no reflow and myocardial damage after PCI. Accordingly, lesions with EA, a large reference area, and low baseline TIMI flow grade could be potential candidates for distal protection.
Limitations
This study was a retrospective analysis from a single center. Bias might have occurred because we excluded lesions that could not be crossed with the IVUS catheter before PCI, in-stent restenotic lesions, heavily calcified lesions, and lesions treated with distal protection devices. ACS patients accounted for almost half (48.9%) of the subjects, and they received thrombectomy before IVUS at the operator's discretion, although univariate analysis showed no significant influence of thrombectomy on EA or coronary flow. Pathological features of DCA samples from lesions with EA might not necessarily have reflected entire plaque. Furthermore, quantitative evaluation of lesions with EA was limited because backward signal attenuation obscured the vessel and quantitative measurement of EA volume was difficult.
Conclusions
EA was detected in the culprit plaques of 35.7% of patients and was more common in patients with ACS than those with SAP. Detection of EA in culprit lesions was a strong independent predictor of no reflow after PCI. EA might indicate that a lesion contains high-risk plaque components that are susceptible to distal embolization.
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